Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Brain Injury

Rutgers NJ Medical School Research: Memory Decline After Head Injury May be Prevented by Slowing Brain Cell Growth

New Brunswick, NJ, September 20, 2017 — Robin Lally reports on Rutgers Today that the excessive burst of new brain cells after a traumatic head injury that scientists have traditionally believed helped in recovery could instead lead to epileptic seizures and long-term cognitive decline, according to a new Rutgers New Jersey Medical School study.

In the September issue of Stem Cell Reports, Viji Santhakumar, Ph.D., associate professor in Department of Pharmacology, Physiology and Neuroscience, and her colleagues, challenge the prevailing assumption by scientists in the field that excessive neurogenesis (the birth of new brain cells) after injury is advantageous. Continue reading

Rutgers Research: Traumatic Brain Injuries May be Helped with Drug Used to Treat Bipolar Disorder

New Brunswick, NJ, May 10, 2017 — A drug used to treat bipolar disorder and other forms of depression may help to preserve brain function and prevent nerve cells from dying in people with a traumatic brain injury, according to a new Rutgers University study.

In research published in Scientific Reports on May 8, Rutgers scientists discovered that lithium — used as a mood stabilizer and to treat depression and bipolar disorder — and rapamycin, a treatment for some forms of cancer, protected nerve cells in the brain and stopped the chemical glutamate from sending signals to other cells and creating further brain cell damage. Continue reading

NJ Commission on Brain Injury Research Awards $6.3M in Grants for Research

Trenton, NJ, May 8, 2015 ― New Jersey Health Commissioner Mary O’Dowd announced today more than $6.3 million in grants for scientific research to develop treatments and cures for disabilities associated with traumatic brain injury.  These grant awards are approved by the New Jersey Commission on Brain Injury Research.

In New Jersey, approximately 175,000 New Jersey residents suffer from traumatic injuries that damage the brain, and 12,000 new injuries occur each year that require inpatient or outpatient treatment.  The economic consequences of physical disabilities due to traumatic brain injury are enormous. Continue reading